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ABSTRACT 
Cancer is becoming one the leading causes of death worldwide, and in particular, 
breast cancer, which is the second highest cause of cancer death for women. 
Approximately 12 percent of US women will develop invasive breast cancer, and about 
40,000 of US women will die from breast cancer in 2015. With better detection and 
treatment options, breast cancer death has been decreasing over the past two decades. 
Despite declining rates in breast cancer death, cancer progression is not well understood. 
There are many studies focused on cancer, but in situ cancer studies are often hard to 
reproduce and can even be impractical.  There is a demand for in vitro cancer models that 
imitate the in vivo environment of cancerous cells and tumor development.  
Numerous models have been developed to better understand normal and 
cancerous breast tissue. Tissue engineering involves the generation of three-dimensional 
(3D) tissue structures by seeding cells onto a scaffold so the cells can attach and 
proliferate into a 3D functional tissue. Unfortunately this approach lacks precise cellular 
placement and fails to create the intricate and complex environment of normal human 
tissue.  The specific microenvironment has been shown to play a key role in metastatic 
cell behavior and in determining phenotype and function of mammary cells. Design of a 
particular 3D arrangement of cells would allow a better understanding of cellular 
behavior and interactions. 
One promising technique for tissue formation is biofabrication, which can 
generate 3D tissues through the delivery of cells and biomaterials layer-by-layer.  
Biofabrication can precisely arrange cells and create scaffolds with more organization 
iii 
and complexity.  Bioprinting is the drop-by-drop deposition of cells and biomaterials.  
Inkjet printing technology has been used to create bioprinters and is an inexpensive way 
to print precise patterns of cell and biomaterials with little reduction in cellular viability, 
with easy pattern modification, and with minimal effect on the substrate.  Inkjet 
bioprinting has great potential for the development of in vitro breast tissue models; the 
general aim of this thesis was to test the capabilities of inkjet bioprinting for creating in 
vitro cancer models.  
The objective of this work was to characterize the interactions of cancerous and 
noncancerous breast cells through several qualitative and quantitative methods after the 
cells were printed into lines of varying distances apart, using a modified inkjet printer as 
a bioprinter.  MCF-10a and MCF-7 cells were printed into two opposing lines of varying 
distances apart onto a collagen coated glass slide, using a bioprinter.  To assess the effect 
of the distance on printed lines of cancer and noncancerous breast cells, several testing 
methods were proposed, and samples were taken at time points of Day 1 and Day 5 after 
printing.  
The results from the collected data lead to several general, key findings.  First, the 
cancerous cells modified the cellular behavior of the noncancerous cells. Second, time 
played a key role in the performance of the cells, particularly for metabolic activity, and 
the overall results points towards a change in cellular behavior with a change in distance 
between lines. Last, the study laid the foundation for potential research to use a bioprinter 
for in vitro cancer models.  Future studies should focus on improvements or alterations to 
the bioprinter and experimental analyses to enhance findings.    
iv 
DEDICATION 
This work is dedicated to Michael Campbell whose love and support made it 
possible for me to complete my graduate studies.  You have always been encouraging of 
my dreams and aspirations no matter how far away they take me from you. This work is 
also dedicated to my parents, Rebecca and Tom, who have shown me the value of hard 
work and commitment and whose love and encouragement have made me who I am.  
Thank you to my brother and sister, Thomas and Jenny, as well as my dearest friends 
who have always brought nothing but joy and laughter to my life and shown me true 
balance.   
v 
ACKNOWLEDGMENTS 
I want to thank my advisor, Dr. Karen Burg, for her support and encouragement 
throughout my graduate school experience.  Her guidance showed me the way even when 
I doubted myself.  I sincerely thank you for your mentorship, your wisdom, and for the 
opportunity for my graduate degree.   
I would also like to thank my committee members, Dr. Timothy Burg and Dr. 
Martine LaBerge.  I am grateful for your knowledge and experience, and your continued 
time and support for my research project.  I would also like to thank Dr. William Bridges 
for helping me with my statistical analysis.   
I would like to acknowledge the faculty and staff in the bioengineering 
department who provided assistance for my project, especially Maria Torres who always 
put a smile on my face.  
I would also like to thank my fellow members of the IBIOE lab, particularly Mrs. 
Kerri Kwist and Mr. Chris Moody.  They helped me tackle the challenges of my project, 
and provided continued support and friendship through my graduate experience.   
vi 
TABLE OF CONTENTS 
Page 
TITLE PAGE .................................................................................................................... i 
ABSTRACT ..................................................................................................................... ii 
DEDICATION ................................................................................................................ iv 
ACKNOWLEDGMENTS ............................................................................................... v 
LIST OF TABLES ......................................................................................................... vii 
LIST OF FIGURES ...................................................................................................... viii 
CHAPTER 
I. LITERATURE REVIEW .............................................................................. 1 
Breast Cancer Statistics............................................................................ 1 
Normal and Cancerous Breast Tissue Models ......................................... 1 
Bioprinting ............................................................................................... 3 
Biofabrication Technologies .................................................................... 4 
Inkjet Bioprinting ..................................................................................... 4 
Future of Bioprinting ............................................................................... 6 
II. INTERACTIONS BETWEEN CANCEROUS AND NONCANCEROUS
BREAST CELLS AFTER PRINTING IN LINES WITH BIOPRINTER .... 8 
Introduction .............................................................................................. 8 
Methods and Materials ............................................................................. 9 
Results .................................................................................................... 26 
Discussion .............................................................................................. 45 
Conclusion ............................................................................................. 50 
REFERENCES .............................................................................................................. 52 
vii 
LIST OF TABLES 
Table Page 
2.1 Number and percentage of green stained and unstained cells collected as a 
comparison to cells collected from experimental and baseline slides  .. 41 
viii 
LIST OF FIGURES 
Figure Page 
2.1 Modified bioprinter ...................................................................................... 12 
2.2 Modified ink cartridge ................................................................................. 13 
2.3 Rubber mask ................................................................................................ 14 
2.4 Stage controller program software screenshot ............................................. 15 
2.5 Example of slide loaded onto platform for print .......................................... 20 
2.6 Hoechst stain for representative baseline slides for Day 1 and Day 5 ......... 27 
2.7 Hoechst stain for representative experimental slides at Day 1 .................... 28 
2.8 Hoechst stain for representative experimental slides at Day 5 .................... 29 
2.9 Glucose and Lactate levels for baseline and experimental slides at Day1 .. 30 
2.10 Glucose and Lactate levels for baseline and experimental slides at Day5 .. 31 
2.11 Biochemical analysis of glucose levels at varying distances ....................... 32 
2.12 Biochemical analysis of lactate levels at varying distances......................... 33 
2.13 The percent reduction of alamarBlue® for baseline and experimental slides at 
Day1 and Day 5 after printing ............................................................... 34 
2.14 The percent reduction of alamarBlue® for baseline and experimental slides at 
varying distances .................................................................................... 36 
2.15 E-cadherin stain for representative baseline slides ...................................... 38 
2.16 E-cadherin stain for representative experimental slides .............................. 40 
2.17 The percentage of green cells stained with E-cadherin for baseline and 
experimental slides at Day1 and Day 5 after printing............................ 42 
2.18 The percentage of green cells for baseline and experimental slides at varying 




Breast Cancer Statistics 
Cancer is becoming one the leading causes of death worldwide with the US 
spending over $100 billion in cancer care [1, 2].  In particular, breast cancer is the second 
highest cause of cancer death for women [1, 3]. Approximately 12 percent of US women 
will have invasive breast cancer, and about 40,000 of US women will die of breast cancer 
in 2015. Fortunately, breast cancer death has been decreasing over the last two decades, 
due to better detection and treatment [1]. Despite declining rates in breast cancer death, 
more research is needed to further knowledge of cancer development and metastasis. 
There are many studies focused on cancer, but in situ cancer studies are often hard to 
reproduce and can even be impractical [1]. There is a demand for in vitro cancer models 
that imitate the environment of cancerous cells and tumor development [3].  
 
Normal and Cancerous Breast Tissue Models 
Numerous models have been developed to better understand normal breast cell 
function and tumor formation and development. Studies have investigated the molecular 
mechanisms, the effect of the microenvironment on cellular behavior, and cancerous 
versus normal cell function [4].  A model system should mimic select natural in vivo 
conditions of breast tissue; the cell types, scaffold, and microenvironment factors are 
important in model selection [5].  Normal tissues have a complex extracellular matrix 
(ECM), with a microenvironment that involves hormones, growth factors, and adhesion 
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molecules [6].  The specific microenvironment has been shown to play a key role in 
metastatic cell morphology, and ECM can determine phenotype and function of 
mammary cells [7, 9-10].   
Two-dimensional (2-D) models have been used to understand the basic functions 
of cellular formation and pathology of breast cells [5-6]. Two-dimensional in vitro 
systems can be designed to study specific cellular function topics such as cellular growth, 
differentiation, cell-cell interaction, and gene expression [8-9]. Though 2D culture 
systems have been used to study breast cancer, 2D models are limited in the reproduction 
of the in vivo environment and have been shown to provide different information than 
three-dimensional (3-D) systems [7, 12-13]. Three-dimensional test systems provide the 
opportunity to combine multiple cell types with a more complex microenvironment that 
better resembles the in vivo condition [13].  Though 3D models offer great research 
opportunity, conventional 3D models are limited by cell placement, reproducibility, 
control of pore dimensions and distribution, and methods of data collection [14].   
Traditional 3D tissue models are usually constructed by building a scaffold as a 
support structure, and then seeding cells onto the scaffold; subsequently, the cells grow 
and proliferate on the scaffold [5, 14-16].  However, this approach lacks precise cells 
placement, and fails to meet the intricate environment of human tissue [14, 16]. Two-
dimensional and 3D tissue models are useful for biological studies and clinical 
applications, but there are many challenges in forming a tissue model, due to the 
complexity of living tissues [17].   
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Both 2D and 3D model systems have been used to study intercellular signaling. 
Intercellular signaling is an important aspect for understanding many complex biological 
processes, and studying intercellular signaling can lead to a better understanding of 
biological behavior [18].  In vivo settings are very intricate and complex, yet many 
cellular tissue models have an imprecise, often random, arrangement of cells [18].  The 
scaffold material and design is known to influence cells, and random cellular placement 
can change the cell behavior [5].  The precise arrangement of cells for a model system 
would allow a better understanding of cellular behavior and interactions and has great 
potential in facilitating the study of cell-cell communication [19].   
 
Bioprinting 
One promising technique for biofabrication, i.e. precision tissue formation, is 
bioprinting. Biofabrication is the biomedical application for additive manufacturing [5, 
14] and bioprinting is a specific technology for drop-by-drop deposition. Additive 
manufacturing is the creation of 3D structures by layer-by-layer construction [5].   
Biofabrication can generate 3D tissues through the delivery of cells and biomaterials 
layer-by-layer [5, 14, 16-18]. Bioprinting involves the precise arrangement of cells on a 
drop-by-drop basis, making the process of creating living tissue more quantitative [18]. 
Hence bioprinting can facilitate the production of scaffolds with more structural integrity, 
organization, and complexity [16]. Other potential applications for bioprinting include 




Multiple technologies could potentially be used to produce a specific arrangement 
of cells for in vitro models [18].  Inkjet printing, extrusion bioprinting, and laser assisted 
bioprinting are a few examples [5, 14, 18]. Inkjet printing can be used to pattern 
biomaterials and cells; previous studies have begun to identify the effects of the printing 
on cell viability [5, 10, 21-22]. Inkjet printing needs a low viscosity bioink for drop 
ejection [5], where bioink is defined as the mixture of cells and biomaterials used for 
bioprinting [14].  Laser-based bioprinters can precisely place cells in a very small 3D 
structure [14, 18].  Since laser-based bioprinters do not involve nozzles, a bioink with 
high viscosity can be printed with a higher degree of precision.  However, the heat of the 
laser-based bioprinter can damage the cells and affect cellular behavior, and the laser 
methods require cells to be embedded in gels [5, 14].   Extrusion-based technology has 
also been suggested.  Extrusion-based approaches can produce constructs with better 
mechanical and structural strength and can be used in conjunction with computer-aided 
design programs to plan structures [14, 18].  Though extrusion methods have a wider 
range of fluid properties, the high shear stress of extrusion-based bioprinting can reduce 
cell viability and result in a lower resolution output [5, 14].   
 
Inkjet Bioprinting 
Inkjet printing technology has great potential for bioprinting.  Inkjet printing 
allows printing of precise patterns of cell and biomaterials in a controlled manner with 
minimal effect on the samples [5, 19]. Inkjet technology originated in the 1980s with the 
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emersion of the first personal computer [14, 16].  Inkjet printers were first used as 
bioprinters in the early 2000s, when ink was replaced with bioink [14].  There are two 
types of inkjet printers, thermal and piezoelectric [14].  Thermal inkjet printers supply a 
pulse to a heating element [14]. The temperature of the ink around the heating element 
increases and forces the ink out of the nozzle of the ink cartridge [14].  A piezoelectric 
inkjet printer causes an electric charge to be applied to piezocrystals; subsequently, the 
crystals vibrate and force a small amount of ink out of the nozzle of the cartridge [14].   
There are several benefits to inkjet printers; specifically, they are relatively 
inexpensive and do not contact the printing surface, thus limiting contamination [11, 14]. 
Printing patterns can be easily changed by simple modification of the corresponding 
software [21]. Inkjet printing can also deliver a high density of cells and biomaterials 
onto a substrate with little reduction in cellular viability [11, 22].  
Bioprinters do have a few limitations, including concern that the heat and 
mechanical stress in thermal inkjet printer can affect cell viability [14, 5, 21]. However, 
several studies have shown that cells can still be viable with increases in temperature, and 
many studies have shown the printing viability of a wide variety of cells such as breast 
cancer cells and neural stem cells [5, 14, 11, 18, 21, 23].  Thorough cleaning of cartridge 
reservoirs and nozzle clogging are major challenges to inkjet printing [24]. Parzel and 
coworkers suggested that this nozzle clogging and failure is the result of salt scale build-
up and aggregated cells on the printhead.  Parzel and colleagues recommended 
ethylenediaminetetraacetic acid (EDTA) to be used in bioink to help with the salt and cell 
build up [25].  The cell viabilities in these preliminary studies were not substantially 
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affected by the use of EDTA; however, more in depth studies must be conducted to 
determine the limits of EDTA volumes and concentrations with respect to cell viability. 
Inkjet bioprinting has great potential for use in the development of in vitro breast 
tissue models [25-26].  A modified inkjet printer has been shown to be an inexpensive 
way to build 3D in vitro models because the printer can easily be modified with high 
throughput (8, 12,19).  
Future of Bioprinting 
Organ transplantation is a lifesaving procedure that has helped many with disease 
conditions that were otherwise incurable [5, 14, 16].  However, as the need for more 
organ donations goes up, the available number of organs remains the same [5, 14, 16].  
The need for organ transplantation greatly surpasses the availability [27]. Organ 
transplantation presents further complications due to tissue rejection, surgical 
complications, and infections [14].  Tissue engineering and biofabrication have the great 
potential to save many lives by replacing or restoring damaged tissue or organs, using the 
patient’s own cells.   
A long term goal of bioprinting is to create fully functional tissues and organs; 
however, organ printing is still an idea of the future [5, 17].  Ideally, bioprinting 
technology would be used to repair and replace damaged tissue or enhance the ability for 
tissue to remodel [16]. Eventually bioprinting could facilitate the development of 3D 
tissues that can be used in experiments or procedures, as well as tumor models for various 
in vitro conditions [5, 18].  However, there are still many challenges to bioprinting, 
including cell viability, pattern repeatability and accuracy, and sterility of printing; there 
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is still a need for better biomaterials with the appropriate mechanical properties [5, 14]. 
Further technological improvements are needed for nozzle cartridge design, more 
functional bioink with higher cell density, multiple bioinks, and better tissue maturation 
processes [5,14].  There is also still some uncertainty on the level of cell damage that 
bioprinting incurs; hence, additional studies to assess this point are needed [5]. Despite 
current limitations, numerous studies are using bioprinting technology, and bioprinting 


















INTERACTIONS BETWEEN CANCEROUS AND NONCANCEROUS BREAST 
CELLS AFTER PRINTING IN LINES WITH BIOPRINTER 
 
Introduction 
Revolutionary medical techniques like organ transplantation and medical device 
implantation are lifesaving procedures that have helped many with chronic and otherwise 
incurable health conditions [5, 14, 16]. The lack of available organ donors and 
complications due to tissue rejection, surgical complications, and infections are constant 
barriers [14].  Tissue engineering and biofabrication have worked to combat these 
obstacles by replacing or restoring damaged tissue or organs using the patient’s own 
cells.  Bioprinting is one promising application of biofabrication that involves the precise 
arrangement of cells on a drop-by-drop basis to create scaffolds with more structural 
integrity, organization, and complexity [16, 18]. Bioprinting has the potential for 
enhanced damaged tissue repair or replacement, and eventually bioprinting could 
accelerate the development of 3D tissues to be used in experiments, procedures, and 
tumor models [5, 16, 18].    
Inkjet printing technology has great promise for bioprinting. Inkjet printing can deliver a 
precise pattern of cell and biomaterials in a controlled manner with little effect on the 
samples [5, 19]. A modified inkjet printer has been shown to build 3D in vitro models 
inexpensively and efficiently with high throughput [8, 12, 19]. Specifically, inkjet 
bioprinting has great potential for development of in vitro breast tissue models [25-26].  
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Though breast cancer death rates are decreasing, there is still a lack of understanding of 
breast cancer development and metastasis, and therefore a need for cancer models that 
mimic in vivo conditions.  Though in vivo conditions are intricate and complex, many 
cellular tissue models have a random arrangement of cells [18]. A model system with the 
precise arrangement of cells would allow a better comprehension of cellular behavior and 
intercellular signaling. Intercellular signaling is an essential aspect in complex biological 
processes, and studying intercellular interactions gives a more thorough knowledge of 
biological behavior [18].  Studies are needed to decipher the interactions of cancerous 
and noncancerous cells to better understand cancer formation and development.  The 
objective of this study was to characterize the interactions of cancerous and noncancerous 
breast cells through several qualitative and quantitative methods after the cells were 
printed into lines of varying distances apart using a modified inkjet printer as a bioprinter.   
 
Materials and Methods 
MCF-10a human mammary gland epithelial cells and MCF-7 adenocarcinomic human 
mammary gland epithelial cells were printed into sets of opposing lines of varying 
distances apart using a modified inkjet printer.  Three different sets of printed lines with 
distances apart of 0 , 200 , and 800  were printed onto collagen- coated glass 
slides.  To assess the effect of the distance on printed lines of cancer and noncancerous 
breast cells, an alamarBlue® assay, an immunofluorescent stain, a glucose and lactate 
analysis, a Hoechst stain, and flow cytometry were employed.  Samples were taken at 
time points of Day 1 and Day 5 after printing to assess the effect of time on the printed 
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lines.  A baseline slide with opposing lines of MCF-10a cells and MCF-10a cells was 
used as a comparison to the experimental slides, which had opposing lines of MCF-10a 
cells and MCF-7 cells. 
Cell Culture 
MCF-10a human mammary gland epithelial cells and MCF-7 adenocarcinomic human 
mammary gland epithelial cells (American Type Culture Collection (ATCC), Manassas, 
VA) were cultured according to manufacturer recommendations.  The MCF-10a cells 
were cultured in a medium containing 500mL of Dulbecco’s Modified Eagle’s Medium 
(DMEM) (DMEM, Atlanta Biologicals®, Lawrenceville, GA) supplemented with 50mL 
of fetal bovine serum (FBS) (Corning, Manassas, NY), 5 mL of antibiotic-antimycotic 
(AA) (Gibco, Great Island, NY), 1mL of fungizone (Gibco), 50  cholera toxin (Sigma, 
St. Louis, MO), and Clonetics® MEGM® SingleQuots® (Lonza, Walkersville, MD).  
The Clonetics® MEGM® SingleQuots® included 2mL bovine pituitary extract, 0.5mL 
human epidermal growth factor, 0.5ml hydrocortisone, 0.5mL insulin, and 0.5mL 
gentamicin.  The MCF-7 cells were cultured in a medium containing 500mL of DMEM 
supplemented with 50mL of FBS, 5 mL of AA, 1mL of fungizone, and 1.125mL of 
insulin (Sigma, St. Louis, MO).  The cells were first cultured in separate T-25 culture 
flasks (Corning, Corning, NY), with the corresponding supplemented DMEM at 37ºC 
and 5% CO2 in a CO2 incubator (Panasonic MCO-18ACL, Chicago, IL).  The 
corresponding culture medium was changed every 24 hours, and the cells were passaged 
to a T-75 culture flask once 80% confluency was reached.  All methods and procedures 
were conducted in a biologic safety hood (SterilGARD III Advance, The Baker 
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Company, Sanford, ME) with proper sterile technique.  The solutions and components 
were prepared with sterile components or were sterilized with a 0.22 µm filter (Corning, 
Corning, NY) under vacuum. 
Bioprinter 
Printer Modification 
The HP deskjet 340 inkjet printer (Hewlett-Packard Development Company, Palo 
Alto, Ca) was modified for use as a bioprinter, as seen in Figure 2.1.  The cover of the 
printer was removed to expose the electronics and the cartridge feeder.   The parts for the 
paper feeder were removed, except for the motor controller of the paper feeder in order to 
serve as an audio and visual alert to trigger the paper feeder. The entire printer was 
mounted on top of a purple 6mm acrylic sheet (Altuglas International, Arkema Group, 
Philadelphia, PA) cut from a Versa laser cutter (Laser & Sign Technology, Punchbowl, 
Australia) and attached to two metal rods on the sides.  A rectangular slit was removed 
from the back of the printer to make room for a MMS micromanipulator stage (Unisense, 
Aarhus, Denmark).  The stage was controlled by a MC-232 motor controller (Unisense).  
A platform was made from multiple layers of 6mm clear acrylic (Altuglas International) 
glued together with superglue, and the acrylic platform was attached to the stage with 
screws and nuts.   
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Figure 2.1: Modified Bioprinter 
 
Cartridge Modification 
HP 26 cartridges (Hewlett-Packard Development Company, Palo Alto, Ca) were 
used in conjunction with the bioprinter, as shown in Figure 2.2. The cartridges had 50 
nozzles, each 80  in diameter, and a delivered a drop size of 140 , at 300 drops per 
inch (dpi). The cartridges were modified to allow removal of the ink, cleaning of the 
cartridges, and loading of bioink. To modify a cartridge, the white plastic plug at the top 
of the cartridge was removed, and the ink was removed from the cartridge using a 
vacuum.  Two cuts, one horizontal and vertical, were made into the cartridge using a 
band saw (Delta Power Equipment Corporation, Anderson County, SC) to remove the 
front of the cartridge.  The cartridge was rinsed with distilled water, and any plastic 
debris was removed.  The foil filter covering the reservoir above the printhead, and the 
paper tab and the blue tab that covers the nozzles, were removed.  The cartridge was then 
rinsed with 70% ethanol (Pharmco-Aaper, Shelbyville, KY) to clean the firing chambers.   
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Figure 2.2: Modified Ink Cartridge 
 
Rubber Mask Modification 
A rubber mask was constructed to seal to the collagen slide and provide a frame 
around the printed lines in order to contain liquid on top of the printed lines, as seen in 
Figure 2.3.  Rectangles 8cm x 2.5cm in size were cut from a  silicone rubber sheet (Fisher 
Scientific, Pittsburgh, PA) using a Versa laser cutter; three squares, 13mm x 13mm in 
size, were subsequently cut out of the rectangles to allow the three sets of prints. 
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Figure 2.3: Rubber Mask 
Software 
The stage was controlled using Microsoft Visual Studio 2010 (Microsoft, 
Redmond, WA); an example screenshot of the stage controller program can be seen in 
Figure 2.4.  The commands were sent using RS232 serial port to the motor controller, and 
the commands were converted to the linear stage.  Patterns were created in GIMP 2 
(GNU Image Manipulation Program) as 300 x 900 pixel images, and then pasted into 
Microsoft Word 2010 (Microsoft).  The images were scaled to 2.54cm x 7.62 cm in 
Microsoft Word so that each drop represented one pixel,and each image was the size of a 
glass slide.  The pattern was repeated in Microsoft Word, each line exactly one inch from 
the next, to allow five prints on the same location. A total of four Microsoft Word 
documents were created and used for each experiment. One document had a three-line 
pattern, with the three lines evenly spaced apart representing the three squares in the 
rubber mask. The other three documents each had an individual line that corresponded to 
the left, middle, and right position of the three squares in the rubber mask.  
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Figure 2.4: Stage Controller Program Software Screenshot 
Cartridge Validation 
Cartridges were validated the day of printing.  The exterior of the nozzle head and the 
connectors of the cartridge were cleaned with a Kimwipe (Kimberly-Clark Worldwide, 
Inc, Irving Texas). The interior cylinder was filled with ink, and then the nozzle head was 
wiped with a Kimwipe to allow the ink to flow.  The exterior head of the nozzle was 
checked for ink build up.  If ink build up did occur, the cartridge was deemed likely 
damaged and another cartridge was used.  The cartridge was inserted into the cartridge 
slot of the bioprinter by pushing the cartridge into the back bottom corner and then 
rotating the cartridge back until it clicked into place. This process involved aligning the 
connectors on the cartridge to the connectors on the slot. A rectangular piece of white 
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paper was cut and placed over a slide, and the slide was loaded onto the platform.  Once 
the cartridge and slide were loaded, the stage controller was moved into position.  A 
validation document was opened in Word and set to print. The result stemming from each 
cartridge was examined. The pattern was not always perfect, but the majority of the 50 
pixels needed to be printed for the pattern to be deemed acceptable.  The process was 
repeated with each cartridge to assess whether a cartridge would be used or not.   
Bioprinter Cleaning and Sterilization 
Before and after printing, the bioprinter was cleaned with 70% ethanol with the 
exception of the acrylic stage and the electronic parts.  Prior to printing, the bioprinter 
and the cartridges were placed in the biologic safety hood and UV sterilized for 10 
minutes.   
Cartridge Cleaning 
After printing, the cartridges were washed with warm water and then distilled 
water (MilliQ, Darmstadt, Germany).  Each cartridge was placed into a beaker (Corning, 
Corning, NY) with 100mL 70% ethanol, with the printhead submerged.  While holding 
the cartridge with two fingers, the 70% ethanol was removed with vacuumed, and the 
cartridge was allowed to air dry.  
17 
Preparation of Bioink 
Once cells were about 80% confluent, the MCF-10a cells and MCF-7 cells were 
trypsinized (Corning, Manassas, NY) and spun down. The MCF-7 cells were resuspended 
in Dulbecco’s Phosphate Buffered Saline (PBS) (Sigma, St. Louis, MO) for a final 
concentration of 2x10
6
cells/mL.  The MCF-10a cells were resuspended in PBS for a final
concentration of 8x10
6
 cells/mL.  To make the bioink, 150  of each cell mixture and
150  of ethylene diamine 
tetraacetic acid (EDTA) (MP Biomedicals, LLC, Solon, OH) were mixed into a separate 
1.5mL centrifuge tube (VWR, Radnor, PA). 
Printing Cells Using the Bioprinter 
Layout of Printing  
The MCF-7 and MCF-10a cells were printed into opposing lines with the 
modified bioprinter.  Three different sets of printed lines 8mm in length with distances 
apart of 0 , 200 , and 800  were printed onto a type I collagen coated glass slide 
(Flexcell International Corporation, Burlington, NC).   The layout of printing cells is the 
same for all the testing methods except for the flow cytometry testing method. For all 
methods except flow cytometry, a baseline slide involved printing the three-line pattern 
with MCF-10a bioink, and then the three individual lines were printed with the MCF-10a 
bioink.  The experimental slide involved printing the three-line pattern with one cell type 
bioink, and then the three individual lines were printed with the other cell type bioink.  
The three individual lines (left, middle, right) for both the baseline and experimental 
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slides were printed at 0 , 200 , and 800  distances apart from the lines in the 
three-line pattern.  The location (left, middle right) on the slide of the three distances 
apart was randomized from slide to slide. For flow cytometry, all three sets of printed 
lines are the same distances apart on each slide, but the distances apart vary from slide to 
slide.  The baseline slide involves printing the three-line pattern with MCF-10a bioink, 
and then printing the second set of lines using the same three-line pattern with the MCF-
10a bioink but with the corresponding distance apart.  The experimental slide involves 
printing the 3 line pattern with one cell type bioink, and then printing the second set of 
lines using the same 3 line pattern with the other cell type bioink but with the 
corresponding distance apart.  For each testing methods except flow cytometery, a total 
of eight slides were used, including three experimental slides plus one baseline slides per 
time point.  For flow cytometry, a total of 24 slides were used, which includes nine 
experimental slides plus three baseline slides per time point.  Samples were taken at time 
points day 1 and day 5 after printing. Each line printed consisted of a total of five passes.  
Each drop from the cartridge delivered roughly one cell per drop, and with about 1000 
drops per cell line, there was a total of 5,000 cells per cell line after five passes.  Each 
square on the slide represented about 10,000 cells per square.   
Printing Procedure 
A routine methodology was used to print a series of variable slides for each 
testing method. The entire bioprinter was placed into a biologic safety hood for printing. 
When ready to begin printing, the first collagen coated slide was placed onto the acrylic 
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platform of the bioprinter as seen in Figure 2.5, and the corners were lightly taped down. 
About 150  of the MCF-10a bioink was placed into the cylinder of one cartridge, and 
then 150  of the MCF-7 bioink was placed into the cylinder of another cartridge. Since 
the baseline slide was printed first, the cartridge with the MCF-10a bioink was inserted 
into the bioprinter.  The stage was loaded into position, and the three-line pattern in the 
Microsoft Word document was sent to print with 5 passes.  Then the stage was moved to 
align for the 0  distance line, and one of the three individual lines was sent to print 
five times. The stage was moved again to print the 200  distance line five times and 
finally, the stage was moved to print the 800  distance line five times. Once the print 
was complete, the slide was removed and placed in a petri dish (VWR, Radnor, PA) with 
a lid. This process was repeated for the experimental slides except the cartridges with 
different bioink were switched between the three-line pattern print and the three 
individual line prints. The routine was performed for all of the slides in a way to 
minimize cartridge switching and time.  
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Figure 2.5: Example of slide loaded onto platform for print 
Post Bioprinting Procedure 
After the cells were printed and placed in a petri dish, they were placed in the 
incubator at 37ºC and 5% CO2 for 3 hours.  After 3 hours, the rubber masks were applied 
to the top of the slide and sealed around the printed line in order to contain liquid. Once 
the rubber mask was firmly attached to the slide, 150  of MCF-10a media was added 
to the each square of the rubber mask.  The petri dishes containing the slide were placed 
back into the incubator.   
Analysis of Cellular Interaction 
Hoechst Stain 
21 
The printed cell lines were fixed with150  of 4% paraformaldehyde (Sigma, 
St. Louis, MO) in each square for 30 minutes.  Each square was rinsed with 150  of 
PBS for 2 minutes.  About 150  of Hoechst dye (Invitrogen, Eugene, OR) with a 
concentration of 2mg/mL was added to each square.  The petri dishes were covered with 
tin foil and stored in a dark place for 15 minutes.  After the 15 minutes, each square was 
rinsed with 150  of PBS for 2 minutes.  Slides were analyzed and images captured 
using a Zeiss Axiovert 40 inverted fluorescent microscope (Carl Zeiss MicroImaging, 
Gottingen, Germany). 
YSI Glucose and Lactate Levels Analysis 
The media added to each square on each slide was collected at Day 1 and Day5 in 
1.5mL centrifuge tubes. The media was changed daily with each square washed with 
150  of PBS before 150  of fresh MCF-10a media was added back to each square.  
The media collected was analyzed using a YSI 2900 (YSI Life Sciences, Yellow Springs, 
OH) for glucose and lactate levels. The experiment was run two times, and the results 
were loaded into Microsoft Excel 2013 (Microsoft, Redmond, WA) worksheet.  The 
glucose and lactate levels were averaged and graphed in Microsoft Excel along with the 
standard deviation.   JMP 11 (SAS Institute Inc, Cary, NC) is a statistics program that 
was used to perform an analysis of variance (ANOVA) statistical analysis on the data 
collected from the YSI experiments.   
alamarBlue®  Assay 
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The alamarBlue® reagent (Invitrogen, Biosource International, Camarillo, CA) 
was added to each square on,  each slide at 10% of the culture medium.  The slides were 
then incubated for three hours at 37ºC and 5% CO2 in the incubator. After incubation, the 
solution from each square was transferred to a 96 well plate (Corning, Corning, NY).  
The samples were assessed using a Synergy 2 Multi-Mode spectrophotometer (BioTek, 
Winooski, Vermont) with the absorbance measured at a wavelength of 570nm and 
600nm. The experiment was run twice, and the results were loaded into a Microsoft Excel 
(Microsoft) worksheet. The percent reduction was calculated using equation 1 and the 
results were averaged and graphed in Microsoft Excel along with the standard deviation.   
JMP was used to perform an ANOVA statistical analysis on the data collected from the 
alamarBlue® experiments.   
Equation 1: Calculation for percent reduction of alamarBlue® using absorbance 
measurements at 570nm and 600nm 
Immunofluorescence Staining 
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The printed cells lines were fixed with150  of 4% paraformaldehyde in each 
square for 30 minutes.  Each square was rinsed with 150  of distilled H2O, PBS, and 
0.2% Tween (Bio-Rad,Hercules, CA) in PBS for 2 minutes.  About 150  of 5% goat 
serum (Sigma Aldrich; St. Louis, MO) was added to each square and let sit for 30mins at 
room temperature.  A dilution of 1:50 of the primary antibody, E-cadherin (Pierce™ 
Thermo Scientific, Rockford, IL), was made in 5% goat serum.  Each square was covered 
with 150  of the primary antibody solution for 2 hours at room temperature.  After two 
hours, each square was rinsed with PBS for two minutes. A dilution of 1:100 of 
secondary antibody (Alexafluor® 488 goat anti-mouse IgG H&L(Life Technologies, 
Eugene, OR) was made in 5% goat serum.  Each square was covered with 150  of the 
secondary antibody solution, the petri dished were covered in tin foil and left in a dark 
place overnight. Each square was rinsed with 150  of PBS and then H2O for 2 
minutes. Slides were analyzed and images captured using a Zeiss Axiovert 40 inverted 
fluorescent microscope.   
Flow Cytometer Experiment 
Each square was rinsed with 150  PBS for 2 minutes, and then each square 
was washed with 150  of 1% goat serum. A dilution of 1:50 of the primary antibody, 
E-cadherin, was made in 1% goat serum.  Each square was covered with 150  of the 
primary antibody solution for 30 minutes in a fridge.  After 30 minutes, each square was 
rinsed with 150  of 1% goat serum three times. A dilution of 1:100 of secondary 
antibody was made in 1% goat serum.  Each square was covered with 150  of the 
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secondary antibody solution, and the petri dishes were covered in tin foil and left in a 
fridge for 20 minutes. Each square was rinsed with 150  of 1% goat serum three times.   
The rubber mask was then taken off and discarded.  A  Fisherbrand cell scraper (Fisher 
Scientific, Pittsburg, PA) was used to scrape the collagen gel and the cells off the slide 
into the petri dish.  About 1mL of PBS was used to rinse the slide, cell scraper, and petri.  
The mixture of PBS, collagen, and cells was collected into a 1.5mL micro centrifuge 
tubes, and 10  of a 10% collagenase (StemCell Technologies Vancouver, Canada) 
solution was added to each centrifuge tube.  The centrifuge tubes were covered with tin 
foil and placed in an incubator at 37ºC for 10 minutes. The centrifuge tubes were spun 
down, the remaining liquid was removed, and the cells were resuspended in 400  of 
4% paraformaldehyde for 15 minutes at room temperature covered with tin foil. The 
centrifuge tubes were again spun down, the remaining liquid was removed, and the cells 
were then resuspended in 200  PBS.   
A separate collection of MCF-7 and MCF-10a cells not used for the bioprinter 
were also used for the flow cytometer.  Approximately 50,000 MCF-10a cells and 50,000 
MCF-7 cells were placed separately into two 1.5mL micro centrifuge tubes for a total for 
four centrifuge tubes.  One MCF-10a and one MCF-7 centrifuge tube were rinsed with 
150  of 1% goat serum.  The two centrifuge tubes were spun down and the remaining 
liquid was removed. The two centrifuge tubes were covered with 150  of the primary 
antibody solution for 30 minutes in a fridge.  After 30 minutes, each of the two tubes 
were rinsed with 150  of 1% goat serum, spun down, and the remaining liquid was 
removed. The two tubes were covered with 150  of the secondary antibody solution, 
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covered in tin foil and left in a fridge for 20 minutes. After 20 minutes, each of the two 
tubes were rinsed with 150  of 1% goat serum, spun down, and the remaining liquid 
was removed. All four centrifuge tubes were resuspended in 400  of 4% 
paraformaldehyde for 15 minutes at room temperature covered with tin foil. The 
centrifuge tubes were again spun down, the remaining liquid was removed, and the cells 
were then resuspended in 1mL of PBS.   
All samples were then analyzed using a Millipore guava easyCyte single sample 
flow cytometer (Millipore, Darmstadt, Germany). The results were loaded into a 
Microsoft Excel worksheet, and the percent of stained green cells was averaged and 
graphed in Microsoft Excel along with the standard deviation.   JMP 11 was used to 
perform an ANOVA statistical analysis on the data collected from the flow cytometry 
experiments.   
Statistical Analysis 
JMP 11 was used to construct a one-way ANOVA statistical analysis for the data 
collected in the YSI, alamarBlue®, and flow cytometer experiments.  When formulating 
a statistical analysis for the experimental data, several aspects needed to be considered 
including the distance between the two printed cell lines (0 , 200 , and 800 ), 
the slide type (baseline or experimental slide), the day the experiment was run (day 1 or 
day 5), which experimental run (run 1 or run 2), and which  particular slide was used.  
The ANOVA model was used to check for distal effects, slide type, and distal x slide type 
effects.  The ANOVA model included these effects in addition to a random “slide” effect 
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A Hoechst stain was used to evaluate cell proliferaltion and the accuracy of 
printed cell lines for the baseline and experimental slides for day 1 and day 5 after 
printing.  The images shown in Figures 2.6-2.8 are representative for the all the images 
captured of the printed cell lines with the varying distances apart.  The images for the 
baseline slides showed a tendency to have a smaller population of cells especailly 
compared to the day 1 and day 5 images (Figure 2.6).   Even for the experimental slides, 
the MCF-10a cells had a smaller popluation of cells compared to the MCF-7 cells, and 
the MCF-7 cells usually clumped together (Figure 2.7-2.8).  For both the baseline and 
experimental slides, the printed cell lines usually had some overlap especially for the 0 
μm and 200 μm distances apart (Figure 2.6-2.8).   
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Figure 2.6: Hoechst stain for representative baseline slides with both printed cells lines 
being MCF-10a cells (Scale bar = 1000μm). (A), (B), and (C) show printed cell lines at 
day 1 after printing with lines at distances apart of 0 μm, 200 μm, and 800 μm 
respectively.  (D), (E), and (F) show printed cell lines at day 5 after printing with lines at 
distances apart of 0 μm, 200 μm, and 800 μm respectively. 
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Figure 2.7: Hoechst stain for representative experimental slides (Scale bar = 1000μm). 
(A), (B), and (C) show printed cell lines at day 1 after printing with lines at distances 
apart of 0 μm, 200 μm, and 800 μm respectively. The top cell line for (A), (B), and (C) is 
MCF-10a and the bottom cell line is MCF-7.   
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Figure 2.8: Hoechst stain for representative experimental slides (Scale bar = 1000μm). 
(A), (B), and (C) show printed cell lines at day 5 after printing with lines at distances 
apart of 0 μm, 200 μm, and 800 μm respectively. The top cell line for (A), (B), and (C) is 
MCF-10a and the bottom cell line is MCF-7.   
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YSI Glucose and Lactate Levels Analysis 
A biochemical analysis for glucose and lactate levels was conducted for both the 
baseline and experimental slide to measure the metabolic activity of the cells.  The results 
were averaged and graphed in Excel along with the standard deviation (Figure 2.9-2.10).   
Figure 2.9: Biochemical analysis of glucose and lactate levels for baseline and 
experimental slides at day1 after printing.  The error bars represent the standard deviation 
and column bars represent mean average of n=6 for experimental and n=2 for baseline.   
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Figure 2.10: Biochemical analysis of glucose and lactate levels for baseline and 
experimental slides at day5 after printing.  The error bars represent the standard deviation 
and column bars represent mean average of n=6 for experimental and n=2 for baseline.   
A statistical analysis was run for the data collected from the YSI experiments, and 
the data was graphed and analyzed using JMP 11 (Figure 2.11-2.12). Though the analysis 
did not show a statistical difference between distances or slide type for glucose and 
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lactate levels, there are some overall patterns from the collected data.  When comparing 
the data from day 1 and day 5, there was an overall increase in lactate and glucose levels 
for both baseline and experimental slides.  There were greater glucose and lactate levels 
for experimental slide when compared to baseline slides.  In general, the glucose and 
lactate levels stay the same or slightly increase with increase of distance between the 
lines.     
Figure 2.11: Biochemical analysis of glucose levels at varying distances (0 μm, 200 μm, 
and 800 μm) separated by slide type (baseline=1 or experimental =2) and day after 
printing (day 1 or day 5) with a smooth trend line.   
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Figure 2.12: Biochemical analysis of lactate levels at varying distances (0 μm, 200 μm, 
and 800 μm) separated by slide type (baseline=1 or experimental =2) and day after 
printing (day 1 or day 5) with a smooth trend line.   
 
alamarBlue®  Assay 
A biochemical analysis using alamarBlue® levels was run for both the baseline 
and experimental slides to measure the overall metabolic activity of the cells.  The 
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percent reduction in alamarBlue® for experimental and baseline slides was averaged, and 
the results were graphed in Excel along with the standard deviation (Figure 2.13).    
 
Figure 2.13: The percent reduction of alamarBlue® for baseline and experimental slides 
at day1 and day 5 after printing.  The error bars represent the standard deviation and 
column bars represent mean average of n=6 for experimental and n=2 for baseline.   
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 A statistical analysis was run for the data collected from the alamarBlue® 
experiments and the data was graphed and analyzed using JMP 11 (Figure 2.14). The 
experimental slides were statistically different from the baseline slides with p<0.05.  On 
average, the experimental slides had a higher percent reduction in alamarBlue® than the 
baseline slides for the corresponding distance.  The change in the percent reduction in 
alamarBlue® was also significantly different (p<0.05) for the varying distance between 
the printed lines.  On average, the percent reduction in alamarBlue® increased as the 
distance between printed cell lines increased.  However, the experimental slide for day 1 
after printing decreased with increase in distance between lines on average (Figure 2.14).   
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Figure 2.14: The percent reduction of alamarBlue® for baseline and experimental slides 
at varying distances (0 μm, 200 μm, and 800 μm) separated by slide type (baseline=1 or 






Immunofluorescence Staining  
 A green immunoflourescence stain for E-cadherin was used to evaluate cell 
proliferaltion and migration of the printed cells line for the baseline and experimental 
slides for day 1 and day 5 after printing.  The images shown in Figure 2.15-2.16 are 
representative for the all the images captured of the printed cell lines with the varying 
distances apart.  The images for the baseline slides showed little to no green flourecence 
(Figure 2.15). The experimental slides showed green flourescence for the MCF-7 cell 
lines, but little to no green flourescence for MCF-10a cells (Figure 2.16).  The green 
flourescence didn’t change when comparing day 1 and day 5 images for both baseline 
and experimental slides.   
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Figure 2.15: E-cadherin stain for representative baseline slides at day 1 after printing 
(Scale bar = 1000μm). (A), (B), and (C) represents E-cadherin stain with printed cell 
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lines at distances apart of 0 μm, 200 μm, and 800 μm respectively. (D), (E), and (F) are 






Figure 2.16: E-cadherin stain for representative experimental slides at day 1 after 
printing.  (Scale bar = 1000μm). (A), (B), and (C) represents E-cadherin stain with 
printed cell lines at distances apart of 0 μm, 200 μm, and 800 μm respectively. (D), (E), 
and (F) are the same E-cadherin stain overlaid with a Hoechst stain.  
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Flow Cytometer Experiment 
The flow cytometer was used to count the number of cells with the green 
immunofluorescence stain for E-cadherin after printing in lines.  The flow cytometer 
calculated the percentage of green cells found for the baseline and experimental slides for 
each varying distance at day 1 and day 5 after printing. The results were averaged and 
graphed in Excel along with the standard deviation (Figure 2.17).   MCF-7 and MCF-10a 
cells not used by the bioprinter were also counted in the flow cytometer as a comparison 
for the cells collected from the baseline and experimental slides (Table 2.1).   
 
Table 2.1: Number and percentage of green stained and not stained cells collected as a 






Percentage of Green 
Cells (%) 
 MCF-7 Not Stained 2991 59 1.97 
 MCF-10a Not 
Stained 1002 144 14.37 
 MCF-7 Stained 2867 2040 71.15 





Figure 2.17: The percentage of green cells stained with E-cadherin for baseline and 
experimental slides at day1 and day 5 after printing.  The error bars represent the standard 
deviation and column bars represent mean average of n=3.   
 
A statistical analysis was conducted for the data collected from the flow 
cytometer experiments, and the data was graphed and analyzed using JMP 11 (Figure 
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2.18). The experimental slides were statistically different from the baseline slides with 
p<0.05.  On average, the baseline slides had a higher percentage of green cells than the 
experimental slides for the corresponding distance.  The change in the percentage of 
green cells was not significantly different (p<0.05) for the varying distance between the 
printed lines.  The baseline and experimental slides followed the same general pattern 
when comparing day 1 and day 5.  The baseline and experimental slide increase 
percentage of green cells with increase in distance between lines for day 1, but decrease 
in percentage of green cells with increase in distance between lines for day 5.    
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Figure 2.18: The percentage of green cells for baseline and experimental slides at varying 
distances (0 μm, 200 μm, and 800 μm) separated by slide type (baseline=1 or 
experimental =2) and day after printing (day 1 or day 5) with a smooth trend line.  The 
green immunoflourescence stain was for E-cadherin.    
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Discussion  
 The objective of this research was to examine the effect of distance on cancerous 
and noncancerous breast cells after printing into opposing lines using a bioprinter.  
Numerous aspects of this study had to be considered to form a quality experimental 
design with relevant practical analyses. The abilities and limitations of the bioprinter and 
ink cartridges, the type of cells, the substrate for printing cells, the overall design of the 
experiment and the experimental analyses were taken into account when setting 
developing this study.   
Limitations of the bioprinter affected several experimental design choices.  The 
height of the cartridge above the printing substrate was constrained due to pattern 
retention.  The best pattern retention placed the cartridge within 1cm of the printing 
substrate.  The further away from the printing substrate, the more splatter from the bioink 
and less pattern retention.  With the height restriction, the printing surface was 
constrained. Slides offered the best option for pattern retention because the cartridge 
could come very close to the printing surface.  Though slides were great for pattern 
retention, slides could not retain any media after printing. Rubber masks were chosen as 
the best solution because they could be applied after printing and retain media to its 
defined square. However, if the rubber mask did not seal properly, there was leakage onto 
other parts of the slide.  The cartridges themselves were not always consistent and had a 
narrow time capacity for printing.  If the cells were sitting in the cartridges for too long, 
the cartridges would become clogged and unable to print.  The bioink was loaded 
immediately before printing, and the cartridges were often switched out after 4 to 5 slides 
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were printed.  The understanding of these bioprinter limitations facilitated a better 
examination of the research question.       
MCF-7 cells, non-invasive human breast cancer cells, were used in this model as 
cancerous cells, and MCF-10a, non-transformed breast cells, were used in this model as 
normal, noncancerous cells [28].  MCF-10a and MCF-7 cells grow cobblestone 
morphologies and maintain their normal cell-cell adhesion on most ECM [10].  Multiple 
printing substrates were considered including collagen type I, a collagen-agarose mixture, 
and agarose based on the prevalence for in vitro models though each gel has advantages 
and disadvantages for tissue test systems [12-13, 20, 29-30, 31]. Based on preliminary 
studies, collagen type I was chosen as the best printing surface because the cells stuck to 
the collagen while still keeping the pattern intact.  The mixture of collagen and agarose 
and the pure agarose gel did not provide an adequate environment for the cells to attach, 
and the cells would almost immediately run off the substrate after printing.   
Collagen type I is the most abundant molecule found in the ECM in normal and 
malignant mammary tissue, and therefore is often used in tissues models [10, 13, 29, 32]. 
Collagen has the right surface for cell adhesion and migration and has good 
biocompatibility and mechanical strength [31, 33]. Cells can quickly remodel collagen, 
and the initial structure of the collagen can quickly change in culture [12, 30, 32]. Despite 
drawbacks, collagen provided an adequate environment for the testing of the research 
question.  A collagen coated slide was chosen for a consistent surface as well as perfectly 
flat printing area, which was crucial for pattern retention.  
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The experimental model for this project was set up using literature as well as 
preliminary studies.  The time points, day 1 and day 5, were chosen based on the previous 
studies for cell viability in a 2-D environment, and the adequate amount of time for the 
cells to communicate [ 31, 34]. After day 5, the MCF-7 and MCF10a decreased in 
proliferation [31, 34]. The distances were chosen based on the general distance for a 
single cell to effectively communicate, which is about 250 μm [35].  The three distances 
represent touching distance (0 μm), a short distance where they can still communicate 
(200 μm), and a distance where the cells can theoretically not communicate (800 μm) 
[34, 35].   
The testing analyses were chosen based on the informative nature and 
compatibility with the bioprinter project and were intended to portray a general picture of 
the cellular activity after printing the cells into lines.  The Hoechst stain was used a visual 
examination of the printed cellular lines. There is a degree of overlap between the lines 
for the distances 0μm and 200μm as seen in Figures 2.6-2.89, but there is almost no 
overlapping of lines for distance 800μm. This implies the cells could definitely 
communicate at 0μm and probably communicate at 200μm, but possibly not 
communicate at distance 800μm.  The MCF-10a cells lines are less dense from day 1 to 
day 5 (Figure 2.6), which might indicate poor MCF-10a attachment and MCF-10a cell 
death at day 5.   The MCF-10a cells did not attach to the collagen as fast as the MCF-7 
cells, which is why the slides were incubated for three hours before adding media. The 
MCF-7 cells printed in clumps of cells rather than more individual cells like the MCF-
10a cells (Figure 2.7-2.8).   
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The analysis of the glucose and lactate levels demonstrated the metabolic activity 
of the MCF-7 and MCF-10a cells, which provided insight into the growth of cells.  For 
normal cellular metabolic activity, cells uptake glucose and produce lactate causing 
glucose levels to decrease while lactate levels increase over time.  From the collected 
data, there was no statistical difference of the glucose and lactate levels between the 
varied distances for both experimental and baseline slides. There was no statistical 
difference between the glucose and lactate levels for the baseline and experimental slides, 
which implies the MCF-7 cells did not affect the metabolic activity of the MCF-10a cells. 
However, there was an overall increase in both glucose and lactate levels from day 1 to 
day 5. The overall increase in glucose and lactate levels from day 1 to day 5 could be due 
to residual glucose left even after each square was washed with PBS and the media 
changed. The overall increase in lactate levels could also suggest the cellular growth for 
both baseline and experimental slides.   
The alamarBlue® is assay is a quantitative analysis to establish the overall health 
of the cell by measuring the metabolic activity [36].  The assay utilizes an oxidation-
reduction indicator that changes color with the reduction of growth media that results 
from cellular growth.  As the cells grow, the metabolic activity of the cell takes up the 
media and results in a reduction of alamarBlue® [36].  A higher reduction of 
alamarBlue® suggests more metabolic activity and therefore more cellular growth.  The 
experimental slides were statistically different than the baseline slide (p<0.05) with the 
experimental slides having a higher percent reduction than the baseline slides. This could 
be due to the MCF-7 cells growing much faster than the MCF-10a cells. The change in 
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distance between the slide also was statistically different for the experimental and 
baseline slide (p<0.05) with the increase in distance causing the increase percent 
reduction of alamarBlue®.  This could suggest that the distance between the lines does 
have an effect on the cells particularly for day 5 rather than day 1 after printing (Figure 
2.14).  
Both the MCF-7 and MCF-10a cells express the protein E-cadherin, and this 
expression can be used for many testing methods [10, 37].  Both the immunofluorescence 
stain and the flow cytometry analysis utilize the E-cadherin expression in MCF-10a and 
MCF-7 cells.   E-cadherin is a transmembrane protein that plays an important role to 
many characteristics of epithelial cells, and studies have shown that intercellular 
interactions between normal and cancerous cells involve E-cadherin [37-39]. E-cadherin 
loss or downregulation is associated with the breakage of cell-cell adhesion, which leads 
to epithelial-mesenchymal transition (EMT) and eventually cancer metastasis [31, 39, 38, 
40].  EMT is considered one of the first mechanisms to breast cancer progression because 
cells lose cell-cell adhesion and become mobile [38-39]. A higher E-cadherin expression 
means a lower ability to move.    
The immunofluorescence stain seen in Figures 2.15 shows the MCF-10a cells 
with little to no green fluorescence.  The MCF-7 cells show sizable green fluorescence, 
and the MCF-10a cells show slightly more green fluorescence in Figure 2.16.  Time does 
not seem to affect the immunofluorescence stain since the day 1 and day 5 pictures did 
not show any difference. Trypsin has been noted to immediately lower E-cadherin 
expression for MCF-10a and MCF-7 because E-cadherin is degraded, but E-cadherin 
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expression was gained back over time [37].  Trypsin should not have modified the E-
cadherin expression because the samples were taken 24 hours after printing when E-
cadherin expression should have been gained back.   
The baseline slides were statistically different from the experimental slides for the 
flow cytometer experiment. From Table 2.1, the not stained MCF-10a cells showed a 
high percentage of 14.37% of green fluorescence while the not stained MCF-7 cells 
showed only 1.97% green fluorescence. Stained MCF-7 and MCF-10a cells showed the 
same 12 percentage difference with the stained MCF-7 cells showing 14.37% and the 
stained MCF-10a cells showing 84.86% (Table 2.1). This could explain why the baseline 
slides had a much higher percentage of green fluorescing cells than the experimental 
slides (Figure 2.18). There was a general pattern when comparing day 1 and day 5 slides.  
The baseline and experimental slide increase percentage of green cells with increase in 
distance between lines for day 1, but decrease in percentage of green cells with increase 
in distance between lines for day 5.   This could suggest that E-cadherin expression is 
affected by the interactions of MCF-7 and MCF-10a cells, and the distance between the 
cells causes a change in expression.   
 
Conclusion 
The results from the collected data of experimental analyses are inconclusive but 
do point towards several general findings.   When comparing performance of the baseline 
and experimental slides, it appears the cancerous MCF-7 cells modify the cellular 
behavior of the noncancerous MCF-10a cells.  Time does play a key role in the activities 
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of the cells, particularly for metabolic activity as the results differ from day 1 to day 5.  
The overall results also point toward a change in cellular behavior with a change in 
distance.   
More studies need to be conducted in order to achieve more conclusive outcomes.  
Several improvements or alterations could be made to achieve more decisive findings.   
The printing substrate and media retention solution presented limitations for experimental 
analyses and could have affected the outcome of the findings.  A printing surface with 
allowing for better cellular communication might enhance the investigation. The 
accuracy of the cartridge greatly hindered several studies, and a better solution to 
cleaning and storage of the cartridge might help facilitate pattern retention.  The study 
laid the foundation for future research to use a bioprinter to measure the effect of distance 
on cancerous and noncancerous cells.  Future studies should focus on improvements or 
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